COLLECTION OF IMMUNE CELL SUBSETS FROM GBM TUMOR SAMPLES OBTAINED FROM PATIENTS PRIOR TO INITIATING A PERSONALIZED NEOANTIGEN VACCINE THERAPY. PERFORM COMPREHENSIVE FACS ANALYSES AND SINGLE CELL RNA SEQUENCING ON ISOLATED CELLS TO DETERMINE FACTORS THAT MAY PREDICT RESPONSE.